Return to work in sick-listed cancer survivors with job loss: design of a randomised controlled trial

BMC Cancer

Martine P van Egmond¹  Saskia FA Duijts³  Sylvia J Vermeulen²  Allard J van der Beek¹  Johannes R Anema¹ 

[1] Dutch Research Center for Insurance Medicine, AMC-UMCG-UWV-VUmc, Amsterdam, the Netherlands

[2] Department of Public and Occupational Health, VU University Medical Center, EMGO+ Institute for Health and Care Research, Van der Boechorststraat 7, Amsterdam, 1081 BT, the Netherlands

[3] Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands

关键词: Unemployment;    Study protocol;    Randomised controlled trial;    Intervention;    Return to work;    Job;    Oncology;    Cancer;   

Others  :  1134527
DOI  :  10.1186/s12885-015-1051-1

 received in 2014-12-18, accepted in 2015-01-28,  发布年份 2015

【 摘 要 】

Background

Despite long-term or permanent health problems, cancer survivors are often motivated to return to work. For cancer survivors who have lost their job, return to work can be more challenging compared to employed survivors, as they generally find themselves in a more vulnerable social and financial position. Cancer survivors with job loss may therefore be in need of tailored return to work support. However, there is a lack of return to work intervention programs specifically targeting these cancer survivors. The number of cancer survivors with job loss in developed countries is rising due to, amongst others, increases in the incidence and survivor rate of cancer, the retirement age and the proportion of flexible employment contracts. Hence, we consider it important to develop a tailored return to work intervention program for cancer survivors with job loss, and to evaluate its effectiveness compared to usual care.

Methods/Design

This study employs a two-armed randomised controlled trial with a follow-up period of 12 months. The study population (n = 164) will be recruited from a national sample of cancer survivors (18–60 years), who have been sick-listed for 12–36 months. Participants will be randomised by using computerized blocked randomisation (blocks of four). All participants will receive usual care as provided by the Dutch Social Security Agency. Additionally, participants in the intervention group will receive a tailored return to work intervention program, which includes vocational rehabilitation and supportive psychosocial components, as well as (therapeutic) placement at work. The primary outcome measure is duration until sustainable return to work; the secondary outcome measure is rate of return to work. Other parameters include, amongst others, fatigue, coping strategy and quality of life. We will perform Cox regression analyses to estimate hazard ratios for time to sustainable return to work.

Discussion

The hypothesis of this study is that a tailored approach for cancer survivors with job loss is more effective, regarding return to work, compared to usual care. The results of this study will provide insight into the ways in which return to work can be facilitated for cancer survivors with job loss.

Trial registration

Netherlands Trial Register: NTR3562.

【 授权许可】

   
2015 van Egmond et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Gosain R, Miller K: Symptoms and symptom management in long-term cancer survivors. Cancer J 2013, 19:405-409.
• [2]Yi J, Kim MA, Tian T: Perceived long-term and physical health problems after cancer: adolescent and young adult survivors of childhood cancer in Korea. Eur J Oncol Nurs 2014, 18:145-150.
• [3]Signaleringscommissie Kanker, KWF kankerbestrijding [Dutch Cancer Society]. Cancer in the Netherlands: trends, forecasts and implications for health care / Kanker in Nederland. Trends, prognoses en implicaties voor zorgvraag. 2004.
• [4]Carlson LE, Angen M, Cullum J, Goodey E, Koopmans J, Lamont L, et al.: High levels of untreated distress and fatigue in cancer patients. Br J Cancer 2004, 90:2297-2304.
• [5]Hewitt M, Rowland JH, Yancik R: Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci 2003, 58:82-91.
• [6]Karki A, Simonen R, Malkia E, Selfe J: Impairments, activity limitations and participation restrictions 6 and 12 months after breast cancer operation. J Rehabil Med 2005, 37:180-188.
• [7]Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M: It’s not over when it’s over: long-term symptoms in cancer survivors–a systematic review. Int J Psychiatry Med 2010, 40:163-181.
• [8]Munir F, Yarker J, McDermott H: Employment and the common cancers: correlates of work ability during or following cancer treatment. Occup Med (Lond) 2009, 59:381-389.
• [9]Peteet JR: Cancer and the meaning of work. Gen Hosp Psychiatry 2000, 22:200-205.
• [10]Lauzier S, Maunsell E, Drolet M, Coyle D, Hebert-Croteau N, Brisson J, et al.: Wage losses in the year after breast cancer: extent and determinants among Canadian women. J Natl Cancer Inst 2008, 100:321-332.
• [11]Mehnert A: Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol 2011, 77:109-130.
• [12]Benach J, Amable M, Muntaner C, Benavides FG: The consequences of flexible work for health: are we looking at the right place? J Epidemiol Community Health 2002, 56:405-406.
• [13]Vermeulen SJ, Tamminga SJ, Schellart AJ, Ybema JF, Anema JR: Return-to-work of sick-listed workers without an employment contract–what works? BMC Public Health 2009, 9:232. BioMed Central Full Text
• [14]Uitvoeringsinstituut Werknemersverzekeringen [Dutch Institute for Employee Benefit Schemes]: Quantitative Reports of Statistics 2013/UWV Kwantitatieve Informatie. 2013.
• [15]Bray F, Jemal A, Grey N, Ferlay J, Forman D: Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol 2012, 13:790-801.
• [16]Hoppers F. Increase In State Pension Age From 1 January 2013. http://legalknowledgeportal.com/2012/10/16/increase-in-state-pension-age-from-1-january-2013/ . 16-10-2012. Dirkzwager advocaten & notarissen N.V., Arnhem, The Netherlands.
• [17]Benach J, Gimeno D, Benavides FG, Martinez JM, Torne MM: Types of employment and health in the European union: changes from 1995 to 2000. Eur J Public Health 2004, 14:314-321.
• [18]Schulz KF, Altman DG, Moher D: CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg 2011, 9:672-677.
• [19]Tamminga SJ, de Boer AGEM, Verbeek JHAM, Frings-Dresen MHW: Return-to-work interventions integrated into cancer care: a systematic review. Occup Environ Med 2010, 67:639-648.
• [20]de Boer AG, Taskila T, Tamminga SJ, Frings-Dresen MH, Feuerstein M, Verbeek JH: Interventions to enhance return-to-work for cancer patients. Cochrane Database Syst Rev 2011, 2:CD007569.
• [21]de Boer AGEM, Frings-Dresen MHW: Employment and the common cancers: return to work of cancer survivors. Occup Med (Lond) 2009, 59:378-380.
• [22]Dutch Cancer Patient Movement (Leven met Kanker Beweging). https://www.kanker.nl/organisaties/levenmetkanker-beweging/2186-homepage. 2014.
• [23]Richtlijn Oncologische Revalidatie [http://www.oncoline.nl/index.php?pagina=/richtlijn/item/pagina.php&id=32518&richtlijn_id=765&tab=2]. 2011.
• [24]Vries HD, Backbier E, Kok G, Dijkstra M: The Impact of social influences in the context of attitude, self-efficacy, intention, and previous behavior as predictors of smoking onset1. J Appl Soc Psychol 1995, 25:237-257.
• [25]van Oostrom SH, Anema JR, Terluin B, de Vet HCW, Knol DL, van Mechelen W: Cost-effectiveness of a workplace intervention for sick-listed employees with common mental disorders: design of a randomized controlled trial. BMC Public Health 2008, 8:12. BioMed Central Full Text
• [26]Franche RL, Corbiere M, Lee H, Breslin FC, Hepburn CG: The Readiness for Return-To-Work (RRTW) scale: development and validation of a self-report staging scale in lost-time claimants with musculoskeletal disorders. J Occup Rehabil 2007, 17:450-472.
• [27]Prochaska JO, DiClemente CC: Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983, 51:390-395.
• [28]Webster K, Cella D, Yost K: The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 2003, 1:79. BioMed Central Full Text
• [29]Chandran V, Bhella S, Schentag C, Gladman DD: Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis. Ann Rheum Dis 2007, 66:936-939.
• [30]Radloff LS: The CES-D Scale. Applied Psychological Measurement 1977, 1:385-401.
• [31]Schroevers MJ, Sanderman R, van Sonderen E, Ranchor AV: The evaluation of the Center for Epidemiologic Studies Depression (CES-D) scale: Depressed and Positive Affect in cancer patients and healthy reference subjects. Qual Life Res 2000, 9:1015-1029.
• [32]Bouma J, Ranchor A, Sanderman R, van Sonderen E: Het meten van symptomen van depressie met de CES-D: een handleiding. Tweede Herziene druk, Groningen; 2012.
• [33]van der Zee CH, Priesterbach AR, van der Dussen L, Kap A, Schepers VPM, Visser-Meily JMA, et al.: Reproducibility of three self-report participation measures: The ICF Measure of Participation and Activities Screener, the Participation Scale, and the Utrecht Scale for Evaluation of Rehabilitation-Participation. J Rehabil Med 2010, 42:752-757.
• [34]Scheurs PJG, van de Willige G, Brosschot JF, Tellegen B, Graus GMH: De Utrechtse Copinglijst: UCL. Swets en Zeitlinger b.v, Lisse; 1993.
• [35]Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S: Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol 1995, 13:1249-1254.
• [36]Schwarz R, Hinz A: Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001, 37:1345-1351.
• [37]Group EQ: EuroQol-a new facility for the measurement of health-related quality of life. HealthPolicy 1990, 15:199-208.
• [38]Lerner D, Amick BC, Rogers WH, Malspeis S, Bungay K, Cynn D: The Work Limitations Questionnaire. Med Care 2001, 39:72-85.
• [39]Verster JC, David B, Morgan K, Olivier B: Validation of the Dutch Occupational Impact of Sleep Questionnaire (OISQ). Ind Health 2008, 46:601-606.
• [40]Davidson JR, MacLean AW, Brundage MD, Schulze K: Sleep disturbance in cancer patients. Soc Sci Med 2002, 54:1309-1321.
• [41]Glasgow RE, Vogt TM, Boles SM: Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health 1999, 89:1322-1327.
• [42]Vermeulen SJ, Anema JR, Schellart AJM, van Mechelen W, van der Beek AJ: Cost-effectiveness of a participatory return-to-work intervention for temporary agency workers and unemployed workers sick-listed due to musculoskeletal disorders: design of a randomised controlled trial. BMC Musculoskelet Disord 2010, 11:60. BioMed Central Full Text
• [43]Lambeek LC, van Mechelen W, Knol DL, Loisel P, Anema JR: Randomised controlled trial of integrated care to reduce disability from chronic low back pain in working and private life. BMJ 2010, 340:c1035.
• [44]Dallal, GE. Randomization Plan Generator. 16-7-2008.
• [45]Heritier SR, Gebski VJ, Keech AC: Inclusion of patients in clinical trial analysis: the intention-to-treat principle. Med J Aust 2003, 179:438-440.
• [46]SPSS Inc. 2009. Chicago, Illinois, USA.
• [47]Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al.: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2014, 127:2893-2917.
• [48]Reichert SJM: The Dutch Pension System, an overview of the key aspects. the Dutch Association of Industry-wide Pension Funds and the Dutch association of Company Pension Funds, Brussels, Belgium; 2014.